Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Tweet this
Rodolfo Perini, PhD
Senior Principal Scientist
Merck & Co., Inc., Rahway, NJ, USA
Poster(s):
E325: Safety of Adjuvant Pembrolizumab (pembro) in a Pooled Analysis of Phase 3 Clinical Trials in Melanoma, Non–Small Cell Lung Cancer (NSCLC), and Renal Cell Carcinoma (RCC)